伦瓦提尼布作为甲状腺癌的紧急初始疗法,具有显著的喉外侵袭
European thyroid journal
|September 18, 2025
概括
伦瓦替尼 (LEN) 在晚期甲状腺癌患者中迅速改善了呼吸道狭窄,避免了侵入性手术. 这种多酶抑制剂作为初始或过桥疗法是有效的,特别是在厌塑性甲状腺癌 (ATC) 中.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 医疗成像医学成像
背景情况:
- 甲状腺癌与喉上的入侵导致危及生命的气道狭窄,往往需要侵入性干预.
- 无塑性甲状腺癌 (ATC) 由于针对性治疗的基因检测延迟而带来了挑战.
研究的目的:
- 评估伦瓦替尼 (LEN) 作为甲状腺癌中呼吸道狭窄的初始和过桥治疗.
- 评估LEN在快速缓解气道阻塞和避免紧急程序方面的有效性.
主要方法:
- 对14名甲状腺癌患者进行了回顾性分析,这些患者患有喉外侵袭,并接受了lenvatinib治疗.
- 通过CT成像评估瘤反应 (RECIST 1.1),重点关注气道直径变化.
- 记录了症状改善和不良事件,包括囊形成.
主要成果:
- 在14名患者中,13名患者在初始林瓦提尼布治疗后显示瘤减少和呼吸道改善.
- 气道直径的中位数改善为15.9%,症状平均在3天内消失.
- 伦瓦提尼布在ATC中BRAF向治疗之前有效作为桥梁治疗.
结论:
- 初始的伦瓦替尼治疗为晚期甲状腺癌的呼吸道狭窄提供了一个快速的,非侵入性的选择.
- 在林瓦提尼布治疗期间,密切监测囊形成至关重要.
- 伦瓦提尼布在ATC遗传测试期间是一个有价值的桥梁疗法.
相关概念视频
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
478
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
478
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


